TriSalus Life Sciences, Inc. Total Assets
TriSalus Life Sciences, Inc. (TLSI) had Total Assets of $62.45 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-06
- 2026-06-30: Assets $62.45M.
- 2026-03-31: Assets $70.98M.
- 2025-12-31: Assets $35.33M.
- 2025-09-30: Assets $36.46M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $62.45M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $70.98M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $35.33M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $36.46M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $41.32M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $28.63M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $23.97M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $27.48M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $32.43M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $17.89M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $24.60M 10-K/A · filed 2025-05-30 | $25.73M 10-K · filed 2024-04-11 |
| 2023-09-30 | $33.55M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $12.24M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $20.52M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $22.00M 10-K · filed 2024-04-11 | $20.19M 10-K · filed 2023-03-22 |
| 2022-09-30 | $251.33M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $250.55M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $250.40M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $250.53M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $250.76M 10-Q/A · filed 2021-12-13 | |
| 2021-06-30 | $251.21M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $251.79M 10-Q · filed 2021-06-28 | |
| 2020-12-31 | $252.01M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |